Vitamin D deficiency testing and supplementation in adult medical practice
Abstract
Vitamin D testing and supplementation are common in adult medical practice, but their clinical use has become uneven. Severe vitamin D deficiency causes osteomalacia, secondary hyperparathyroidism, bone pain, proximal muscle weakness, and increased skeletal fragility. In selected high-risk adults, testing and treatment are clearly justified. In contrast, routine screening of asymptomatic adults and broad supplementation for non-skeletal disease prevention are not well supported by trial evidence. This review evaluates vitamin D deficiency testing and supplementation in adult practice, with attention to bone health, falls, fatigue, immune claims, overtesting, toxicity, and high-risk groups. PubMed-indexed guidelines, systematic reviews, randomized trials, meta-analyses, and toxicity reviews were examined. Current evidence supports targeted testing in adults with clinical suspicion of deficiency, osteoporosis or fragility fracture, osteomalacia features, malabsorption, chronic kidney or liver disease, bariatric surgery, medicines affecting vitamin D metabolism, persistent hypocalcaemia, or other clear risk factors. The 2021 US Preventive Services Task Force found insufficient evidence to assess the balance of benefits and harms of screening asymptomatic community-dwelling nonpregnant adults. The 2024 Endocrine Society guideline also advised against routine 25-hydroxyvitamin D testing in generally healthy populations without established indications. Supplementation remains…
Read the paper
Related studies
- Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study
- Osteoporosis-related fractures after spinal cord injury: a retrospective study from Brazil
- Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
- Lack of Association between Vitamin D Insufficiency and Cardiovascular or Fracture Risk: A UK Biobank Study
- Muscle strength and body composition are clinical indicators of osteoporosis
- Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.